LITFULO caps 50 mg 30 pce

7680696950013 CH-69695 L04AF08 07.15.0.
LITFULO caps 50 mg 30 pce
LITFULO caps 50 mg 30 pce
LITFULO caps 50 mg 30 pce
1 / 3
google

Details

Product number
6969501
CPT
-
Packaging group
30
Unit
Kapsel(n)
Composition
ritlecitinibum 50 mg ut ritlecitinibi tosilas, cellulosum microcristallinum, lactosum monohydricum 21.269 mg, crospovidonum, glyceroli dibehenas, Kapselhülle: hypromellosum, E 171, E 172 (flavum), E 133, Drucktinte: lacca, propylenglycolum, ammoniae solutio concentrata, E 172 (nigrum), kalii hydroxidum, pro capsula.

Articles (1)

Litfulo 50 mg, Hartkapseln
Kapseln
30
View

Official Swissmedic V2 data

Additional information from the official database

Official medical documents

Patient information leaflet
Allemand
01/05/2025
Patient information leaflet
Français
01/05/2025
Patient information leaflet
Italien
01/05/2025
Professional SmPC
Allemand
01/05/2025
Professional SmPC
Français
01/05/2025
Professional SmPC
Italien
01/05/2025

Detailed composition

Substance Quantity Type Category
(N/A)
50.0 MG Substance Wirkstoff (Principe actif)
(N/A)
- Substance WIZUS
(N/A)
- Substance HNIDK
(N/A)
21.269 MG Substance HBESI
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance HNIDK
(N/A)
- Substance FNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance FIMDK
(N/A)
- Substance HNIDK
(N/A)
- Substance Hilfsstoff ohne Deklarationspflicht (Excipient sans obligation de déclaration)
(N/A)
- Substance HNIDK
(N/A)
- Substance FTODK
(N/A)
- Substance HNIDK

Authorization holder

Pfizer AG

8052 Zürich

Authorization information

Swissmedic authorization number
69695
Drug name
Litfulo, Hartkapseln
Galenic form
KAHA
ATC Code
L04AF08
Authorization status
Z
Dispensation category
B
First authorization
03/02/2025
Authorization expiration date
02/02/2030
IT number
07.15.0.
Domain
Human medicine
Field of application
Behandlung von schwerer Alopecia areata (≥50 % der Kopfhaut betroffen) bei Erwachsenen bis maximal 65 Jahre und Jugendlichen ab einem Alter von 12 Jahren, die für eine systemische Therapie in Frage kommen

Packaging details

Description (FR)
LITFULO caps 50 mg 30 pce
Description (DE)
LITFULO Kaps 50 mg 30 Stk
Market launch
03/02/2025
Narcotic (BTM)
No